Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Isotretinoin measurement |
Component |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Isotretinoin adverse reaction (disorder) |
Causative agent |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Allergy to isotretinoin |
Causative agent |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
|
Isotretinoin overdose |
Causative agent |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Accidental isotretinoin overdose |
Causative agent |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Intentional isotretinoin overdose |
Causative agent |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
overdosis af isotretinion, uvist med hvilken hensigt |
Causative agent |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Isotretinoin [topical] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
|
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
|
Product containing precisely isotretinoin 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
|
Product containing precisely isotretinoin 20 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
|
Product containing precisely isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
|
Retinoinsyreembryopati |
Causative agent |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
|
Product containing precisely isotretinoin 10 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
|
Product containing precisely isotretinoin 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
|
Product containing isotretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing erythromycin and isotretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
2 |
Isotretinoin 30 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
|
isotretinoin til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
|
Product containing isotretinoin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Allergy to isotretinoin |
Causative agent |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Isotretinoin therapy (procedure) |
Direct substance |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely isotretinoin 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isotretinoin 5 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isotretinoin 20 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isotretinoin 20 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isotretinoin 10 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isotretinoin 10 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isotretinoin 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isotretinoin 40 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Isotretinoin 30 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Isotretinoin 30 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isotretinoin 10 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isotretinoin 5 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isotretinoin 20 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isotretinoin 40 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Isotretinoin 30 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Isotretinoin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Erythromycin- and isotretinoin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
2 |
Erythromycin and isotretinoin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
2 |
Isotretinoin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Product containing only isotretinoin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Isotretinoin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |
Erythromycin and isotretinoin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
2 |
A rare teratogenic embryofetopathy due to exposure to isotretinoin, an oral synthetic vitamin A derivative, which is used to treat severe recalcitrant cystic acne. Exposure to isotretinoin during the first trimester of pregnancy has been associated with an increased risk of spontaneous abortions and severe birth defects including serious craniofacial (microcephaly, asymmetric crying facies, microphthalmia, developmental abnormalities of the external ear, ocular hypertelorism), cardiovascular (conotruncal heart defects, aortic arch abnormalities), and central nervous system (hydrocephalus, microcephaly, lissencephaly, Dandy-Walker malformation, cognitive deficit) anomalies and thymic aplasia. |
Causative agent |
True |
Isotretinoin (substance) |
Inferred relationship |
Some |
1 |